CoChat
Sign Up
Cited by 74

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program

Goldberg, R., Temprosa, M., Otvos, J., Brunzell, J., Marcovina, S., Mather, K., Arakaki, R., Watson, K., Horton, E., Barrett-Connor, E.·2013·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2013-1452
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2013-1452

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 24

  1. [1]1. Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003;52:453–462 [DOI] [PubMed] [Google Scholar]
  2. [4]4. Mayer-Davis EJ, Vitolins MZ, Carmichael SL, et al. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology Study. Ann Epidemiol. 1999;9:314–324 [DOI] [PubMed] [Google Scholar]
  3. [5]5. Kriska AM, Caspersen CJ. Introduction to the collection of physical activity questionnaires. Med Sci Sports Exerc. 1997;29:5–9 [PubMed] [Google Scholar]
  4. [7]7. Nishimura A, Sawai T. Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer. Clin Chim Acta. 2006;371:163–168 [DOI] [PubMed] [Google Scholar]
  5. [8]8. Otvos JD, Jeyarajah EJ, Bennett, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem. 1992;38:1632–1638 [PubMed] [Google Scholar]
  6. [9]9. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med. 2006;26:847–870 [DOI] [PubMed] [Google Scholar]
  7. [10]10. Purnell JQ, Marcovina SM, Hokanson JE, et al. Levels of Lp(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM: results from follow-up in the Diabetes Control and Complications Trial. Diabetes. 1995;44:1218–1226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. [11]11. Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28:888–894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. [12]12. Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225–1236 [DOI] [PubMed] [Google Scholar]
  10. [15]15. Siri-Tarino PW, Williams PT, Fernstrom HS, Rawlings RS, Krauss RM. Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity (Silver Spring). 2009;17:1768–1775 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. [16]16. Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51:2405–2412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. [17]17. Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol. 2006;17:412–417 [DOI] [PubMed] [Google Scholar]
  13. [18]18. Shepherd J, Caslake MJ, Lorimer AR, Vallance BD, Packard CJ. Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects. Arteriosclerosis. 1985;5:162–168 [DOI] [PubMed] [Google Scholar]
  14. [19]19. Cromwell WC, Otvos JD, Keyes MJ, et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—implications for LDL Management. J Clin Lipidol. 2007;1:583–592 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. [20]20. Rosenson RS, Brewer HB, Jr, Chapman MJ, et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem. 2011;57:392–410 [DOI] [PubMed] [Google Scholar]
  16. [21]21. Otvos JD, Collins D, Freedman DS, et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation. 2006;113:1556–1563 [DOI] [PubMed] [Google Scholar]
  17. [22]22. Flynn MM, Zmuda JM, Milosavljevic D, Caldwell MJ, Herbert PN. Lipoprotein response to a National Cholesterol Education Program step II diet with and without energy restriction. Metabolism. 1999;48:822–826 [DOI] [PubMed] [Google Scholar]
  18. [24]24. Weiss R, Otvos JD, Flyvbjerg A, et al. Adiponectin and lipoprotein particle size. Diabetes Care. 2009;32:1317–1319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. [25]25. Pardina E, Baena-Fustegueras JA, Catalán R, et al. Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content. Obes Surg. 2009;19:894–904 [DOI] [PubMed] [Google Scholar]
  20. [26]26. Clarenbach JJ, Vega GL, Adams-Huet B, Considine RV, Ricks M, Sumner AE. Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans. J Investig Med. 2007;55:187–194 [DOI] [PubMed] [Google Scholar]
  21. [27]27. Mather K, Funahashi T, Matsuzawa Y, et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes. 2008;57:980–986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. [28]28. Brunzell JD, Zambon A, Deeb SS. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta. 2012;1821:365–372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. [29]29. Ganguly R, Schram K, Fang X, Rodrigues B, Thong FS, Sweeney G. Adiponectin increases LPL activity via Rho/ROCK-mediated actin remodelling in adult rat cardiomyocytes. Endocrinology. 2011;152:247–254 [DOI] [PubMed] [Google Scholar]
  24. [30]30. Kuusi T, Ehnholm C, Viikari J, Härkönen R, Vartiainen E, Puska P, Taskinen MR. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res. 1989;30:1117–1126 [PubMed] [Google Scholar]

Cited by

Sorted by citations

See all 74

Metadata

Authors
Goldberg, R., Temprosa, M., Otvos, J., Brunzell, J., Marcovina, S., Mather, K., Arakaki, R., Watson, K., Horton, E., & Barrett-Connor, E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2013-10
Volume
98
Issue
10
Pages
3989-3998
ISSN
  • 0021-972X
  • 1945-7197
DOI
10.1210/jc.2013-1452
Cited by
74
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review